Merck to Lay Off Over 150 Employees as Gardasil Production Winds Down in N.C.
SOURCENews reportView the filing ↗
What we know
Location: North Carolina, USA.
Department affected: Gardasil Production.
Based on news reporting.
Summary
Merck & Co. is set to lay off over 150 employees as it winds down production of its Gardasil vaccine at its North Carolina facility. This decision comes as part of a strategic shift in the company's operations, although specific reasons for the production halt were not detailed in the article. The layoffs will affect workers directly involved in the Gardasil production line, marking a significant change in the company's workforce dynamics in the region. Merck's restructuring efforts reflect broader trends in the pharmaceutical industry, but the focus remains on the impact on its North Carolina operations.
Merck & Co., Inc. cut 150 jobs in NC affecting its Gardasil Production team as of February 27, 2026.
That is roughly 0.2% of the 70,000 people Merck & Co., Inc. employs.
LayoffTalk has tracked 34 layoff events at Merck & Co., Inc. since May 2025, including 146 jobs documented in official WARN filings, with 31 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Merck & Co., Inc.
Recent tracked events at this company.
Recent layoffs in NC
Other companies with tracked events in the same state.